The effort has implications for international travel and allocating vaccines – but the precise quantitative tests necessary for this do not, as yet, exist.
Welcome to the calm before the Covid-19 storm.
The largest medtech companies have differing business development strategies, but tend to be on the same page on R&D spending.
Suddenly 2020’s medtech M&A landscape looks very different.
Chembio’s antibody test is the first to have its authorisation revoked. It might not be the last.
The German group has come late to antibody testing, but has punchy accuracy data and a possible means of neutralising some of the competition.